Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA 19-9 levels

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 5, 1999, Pages 1039-1046

  Abrams, Ross A ^a   Grochow, Louise B ^a   Chakravarthy, Anuradha ^a   Sohn, Taylor A ^a   Zahurak, Marianna L ^a   Haulk, Thomas L ^a   Ord, Sarah ^a   Hruban, Ralph H ^a   Lillemoe, Keith D ^a   Pitt, Henry A ^b   Cameron, John L ^a   Yeo, Charles J ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adenocarcinoma; Chemotherapy; Pancreatic; Periampullary; Radiotherapy

Indexed keywords

CA 19-9 ANTIGEN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; BEAM THERAPY; BILE DUCT CARCINOMA; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DUODENUM CARCINOMA; FEMALE; GASTROINTESTINAL TOXICITY; HEPATITIS; HUMAN; LYMPH NODE METASTASIS; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT FAILURE; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; AGED; AMPULLA OF VATER; ANTIMETABOLITES, ANTINEOPLASTIC; CA-19-9 ANTIGEN; CHEMOTHERAPY, ADJUVANT; COMMON BILE DUCT NEOPLASMS; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032784821     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00107-8     Document Type: Article

References (31)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics 1997. CA. 47:1997;5-27.
2. Yeo C.J., Cameron J.L., Sohn T.A., Lillemoe K.D., Pitt H.A., Talamini M.A., Hruban R.H., Ord S.E., Sauter P.K., Coleman J.A., Zahurak M.L., Grochow L.B., Abrams R.A. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990's. Pathology, complications, and outcomes. Ann Surg. 226:1997;248-260.
3. Allema J.H., Reinders M.E., van Gulik T.M., Koelemay M.J.W., Van Leeuwen D.J., de Wit L.T., Gouma D.J., Obertop H. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 75:1995;2069-2076.
4. Bottger T.C., Storkel S., Wellek S., Stockle M., Junginger T. Factors influencing survival after resection of pancreatic cancer - a DNA analysis and histomorphologic study. Cancer. 73:1994;63-73.
5. Geer R.J., Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 165:1993;68-73.
6. Sperti C., Bonadimani B., Pasquali C., Piccoli A., Cappellazzo F., Rugge M., Pedrazzoli S. Ductal adenocarcinoma of the pancreas Clinicopathologic features and survival . Tumori. 79:1993;325-330.
7. Willett C.G., Lewandrowski K., Warshaw A.L., Efird J., Compton C.C. Resection margins in carcinoma of the head of the pancreas - implications for radiation therapy. Ann Surg. 217:1993;144-148.
8. Yeo C.J., Hruban R.H., Kern S.E., Abrams R.A., Grochow L.B., Griffin C.A., Cameron J.L. Adenocarcinoma of the pancreas Factors influencing outcome after pancreaticoduodenectomy - the Johns Hopkins experience . Cancer Bull. 46:1994;504-510.
9. Yeo C.J., Cameron J.L., Lillemoe K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., Dooley W.C., Coleman J., Pitt H.A. Pancreaticoduodenectomy for cancer of the head of the pancreas 201 patients. Ann Surg. 221:1995;721-733.
10. Abrams R.A., Grochow L.B. Adjuvant therapy with chemotherapy and radiation therapy in management of carcinoma of the pancreatic head. Surg Clin North Am. 75:(5):1995;925-938.
11. Yeo C.J., Abrams R.A., Grochow L.B., Sohn T.A., Ord S.E., Hruban R.H., Zahurak M.L., Dooley W.C., Coleman J.A., Sauter P.K., Pitt H.A., Lillemoe K.D., Cameron J.L. Pancreaticoduodenectomy for pancreatic adenocarcinoma Postoperative adjuvant chemoradiation improves survival . Ann Surg. 225:1997;621-636.
12. Bluemke D.A., Abrams R.A., Yeo C.J., Cameron J.L., Fishman E.K. Recurrent pancreatic adenocarcinoma Spiral CT evaluation following the Whipple procedure . Radiographics. 17:1997;303-313.
13. Griffin J.F., Smalley S.R., Jewell W., Paradelo J.C., Reymond R.D., Hassenein R.E.S., Evans R.G. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 66:1990;56-61.
14. Tepper J., Nardi G., Suit H. Carcinoma of the pancreas Review of the MGH experience from 1963 to 1973 . Cancer. 37:1976;1519-1524.
15. Ahlgren J.D. Chemotherapy for pancreatic carcinoma. Cancer. 78:(3):1996;654-663.
16. Douglass H.O. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst. 80:1988;751-755.
17. Flickinger J.C., Jawalekar K., Deutsch M., Webster J. Split course radiation therapy for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 15:1988;359-364.
18. Moertel C.G., Frytak S., Hahn R.G., O'Connell J.O., Reitemeir R.J., Rubin J., Schutt A.J., Weiland L.H., Childs D.S., Holbrook M.A., Lavin P.T., Livston E., Spiro H., Knowlton A., Kalser M., Barkin J., Lessner H., Mann-Kaplan R., Ramming K., Douglas H.O., Thomas P., Nave H., Bateman J., Lokich J., Brooks J., Chaffey J., Corson J.M., Zamcheck N., Novak J.W. Therapy of locally unresectable pancreatic carcinoma A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil . Cancer. 48:1981;1705-1710.
19. Kalser M.H., Ellenberg S.S. Pancreatic cancer - adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 120:1985;899-903.
20. Cameron J.L., Pitt H.A., Yeo C.J., Lillemoe K.D., Kaufman H.S., Coleman J.A. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 217:1993;430-438.
21. Komaki R., Hansen R., Cox J.D., Wilson F. Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 15:1988;1447-1452.
22. Komaki R., Wadler S., Peters T. High dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. Cancer. 69:1992;2807-2812.
23. Carducci M.A., Abrams R.A., Yeo C.J., Hruban R.H., Zahurak M.L., Cameron J.L., Grochow L.B. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 35:1996;143-150.
24. Crown J., Casper E.S., Botet J., Murray P., Kelsen D.P. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol. 9:1991;1682-1686.
25. Riess H., Htun P., Loffel J., Huhn D. Chemotherapy for patients with adenocarcinoma of the pancreas. Cancer Res. 142:1996;415-424.
26. Rubin J., Gallagher J.G., Schroeder G., Schutt A.J., Dalton R.J., Kugler J.W., Morton R.F., Mailliard J.A., Burch P.A. Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer. 78:1996;1888-1891.
27. O'Connell M.J., Martenson J.A., Wieand H.S., Krook J.E., MacDonald J.S., Haller D.G., Mayer R.J., Gunderson L.L., Rich T.A. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 331:1994;502-507.
28. Evans D.B., Abbruzzese J.L., Cleary K.R., Buchholz D.J., Fenoglio C.J., Collier C., Rich T.A. Preoperative chemoradiation for adenocarcinoma of the pancreas Excessive toxicity of prophylactic hepatic irradiation . Int J Radiat Oncol Biol Phys. 33:(4):1995;913-918.
29. Jaffee E.M., Schutte M., Gossett J., Morsberger L.A., Adler A.J., Thomas M., Greten T.F., Hruban R.H., Yeo C.J., Griffin C.A. Development and characterization of a cytokine secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am. 4:1998;194-203.
30. Klinkenbijl J.H.G., Sahmoud T., van Pel R., Couvreur M.L., Veenhof C.C.H.N., Armaud J.P., Hennipman A., Wils J., Jeekel J. Radiotherapy and 5-FU after curative resection for cancer of the pancreas and peri-ampullary region A phase III trial of the EORTC and GITCCG . (Abstr. 11239) Eur J Cancer. 33:(8):1997;1997.
31. Regine W.F., Abrams R.A. Adjuvant therapy for pancreatic cancer Back to the future . Int J Radiat Oncol Biol Phys. 42:(1):1998;59-63.